Navigation Links
GenVec Reports Fourth Quarter And 2012 Year-End Financial Results
Date:3/22/2013

nal Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to support the Company's RSV vaccine program.  This grant will be used to further advance the novel pediatric RSV vaccine.
 
  • Promising data were presented on GenVec's RSV vaccine program at the 8th Annual International Respiratory Syncytial Virus Symposium, demonstrating that GenVec's pre-clinical, universal RSV vaccine candidate is highly immunogenic and produces durable and broad protection from a single intramuscular administration.  Protection in cotton rat and mouse models was characterized by functional RSV neutralizing antibodies and no disease potentiation was observed.
     
  • Encouraging preclinical proof of concept data generated in non-human primates involving GenVec's RSV vaccine program were presented at the Keystone Symposia 2012 Meeting on Viral Immunity and Host Gene Influence.  GenVec's vaccine technology induced neutralizing antibody and significant T-cell responses with a single administration.  The immune responses were consistent with protective responses without disease potentiation, and multiple administrations increased the neutralizing antibody responses.
  • HSV Vaccine

  • GenVec conducted a successful pre-IND interaction with the U.S. Food and Drug Administration (FDA) to obtain guidance on the development plan for its vaccine against herpes simplex virus (HSV).  The outcome of the pre-IND interaction was obtaining clarification on the nonclinical, clinical, and chemistry, manufacturing, and control (CMC) requirements that need to be met in order to submit an acceptable IND.
  • Data were presented on GenVec's HSV vaccine program at the Keystone Symposia meeting on Immunological Mechanisms of Vaccination.  The Company disclosed that a single administration of its genetic vaccine was effective against HSV2 in two industry-accepted HSV disease models.
  • Mala
    '/>"/>

    SOURCE GenVec, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012
    2. GenVec Appoints Cynthia Collins as President and CEO
    3. GenVec Reports Inducement Award
    4. GenVec Announces Conditional Approval of FMD Vaccine for Cattle
    5. GenVec to Release Second Quarter 2012 Financial Results and Conduct a Conference Call on August 9, 2012
    6. GenVec Reports Second Quarter 2012 Financial Results
    7. GenVec Reports Third Quarter 2012 Financial Results
    8. GenVec to Present at 25th Annual ROTH Conference
    9. GenVec To Release Fourth Quarter And Year-end 2012 Financial Results And Conduct A Conference Call On March 22, 2013
    10. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
    11. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2014)... , Aug. 29, 2014 Thoratec Corporation ... device-based mechanical circulatory support therapies to save, support and ... in the 2014 Morgan Stanley Global Healthcare Conference on ... , President and Chief Executive Officer, will provide an ... Daylight Time (9:55 a.m., Pacific Daylight Time).   ...
    (Date:8/29/2014)... 29, 2014 Research and Markets  has announced ... Insight 2014" report to their offering. ... one of the largest segments of pharmaceuticals industry. The numbers ... the available therapies were unable to meet the market requirements. ... for CNS disorder, especially over the past two decades. The ...
    (Date:8/29/2014)... SILVER SPRING, Md. , Aug. 29, 2014 /PRNewswire/ ... today that the U.S. District Court for the District ... in its favor in the company,s case against Sandoz, ... opinion, Judge Peter Sheridan ruled that U.S. ... Sandoz, Inc., and enjoined Sandoz from marketing its generic ...
    Breaking Medicine Technology:US CNS Disorders Drug Pipeline Insight 2014 2District Court Decision Received In Remodulin Patent Case 2
    ... Oswego, Oregon based ThermoGear, Inc., partnered with DVM Solutions, ... new high technology veterinary surgical system that took place ... Florida.  The Chillbuster®VET Surgical Blanket and Cage Mat are ... Veterinarians who have been testing the system. ...
    ... Corporation (NYSE: BSX ) today announced the ... which is designed to assess the safety and performance ... single-blind, non-inferiority trial will compare the SYNERGY Stent to ... a single de novo native coronary artery ...
    Cached Medicine Technology:High Tech Vet Medical Warming System Introduced at Orlando 2High Tech Vet Medical Warming System Introduced at Orlando 3Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent 2Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent 3Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent 4
    (Date:9/1/2014)... Liver is the largest organ inside the ... the body in barring itself from poisons, helps in digestion ... also plays many important functions such as protein production, blood ... Many illnesses can affect the liver, an organ the size ... the right side of the abdomen, reducing its capabilities to ...
    (Date:9/1/2014)... "Women struggle with weight gain typically associated ... as early as 15, if not earlier. Women ... and downs of hormone related weight gain. The ... seems to rage against the hidden and ever-present hormones ... 40's begin to face menopause and related changes, these ...
    (Date:9/1/2014)... Spain Monday 1 September 2014: Permanent atrial fibrillation ... AF, according to research in more than 6 000 ... Vanassche from Belgium. The findings suggest that a simple ... doctors to better estimate stroke risk. , Ischaemic stroke ... accounting for over a million deaths and many more ...
    (Date:9/1/2014)... York (PRWEB) September 01, 2014 ... retrieve, organize and analyze biological and genetic data. ... the activity of developing software tools to generate ... to be confused with biological computation. While bioinformatics ... understanding of biology can its related concepts, biological ...
    (Date:9/1/2014)... September 01, 2014 Top10BestSEOHosting.com has ... many web host suppliers carefully, Top10BestSEOHosting.com is here ... the best web hosting suppliers in 2014. , ... clients with a top-of-the-line shared hosting plan. The ... easy-to-use platform that is affordable, accessible and powerful ...
    Breaking Medicine News(10 mins):Health News:Global Liver Diseases and Therapies Market- The Key Basics by Transparency Market Research 2Health News:Global Liver Diseases and Therapies Market- The Key Basics by Transparency Market Research 3Health News:Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today 2Health News:Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today 3Health News:Permanent AF doubles risk of stroke compared to paroxysmal AF 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 4Health News:Why Top10BestSEOHosting.com Calls Them Great Web Hosting Suppliers 2
    ... , MONDAY, Oct. 3 (HealthDay News) -- Even ... as depression, vision problems and difficulty thinking, according to a ... Canadian Stroke Congress in Ottawa, suggest new guidelines are needed ... said. "There is no such thing as a mild ...
    ... MDA recent study accepted for publication in Molecular Endocrinology, ... exposure to environmentally relevant doses of bisphenol A (BPA) ... that may increase the propensity to develop cancer. ... specific industrial purposes, is detected in body fluids of ...
    ... Not only are smokers twice as likely to have strokes, ... have them, according to a study presented today at the ... researchers studied 982 stroke patients (264 smokers and 718 non-smokers) ... of stroke patients who smoked was 58, compared to age ...
    ... is common among patients with gout. According to the ... peer-reviewed journal of the American College of Rheumatology (ACR), ... foot-related pain, impairment and disability. Gout patients also reported ... important factors for selecting footwear. Gout is a ...
    ... South Africa and Brazil become happier as they age. New ... developing country can significantly improve the wellbeing of its older ... people in South Africa and Brazil improved between 2002 and ... social policies, according to a study from the New Dynamics ...
    ... Oct. 2 (HealthDay News) --,Children can enjoy some Halloween candy ... Mitchell, a Chicago dentist. Mitchell said the key to ... of candy children eat, but also how long the sugar ... possible after eating candy may keep harmful bacteria from developing, ...
    Cached Medicine News:Health News:Mild Strokes May Have Hidden Effects 2Health News:BPA exposure in utero may increase predisposition to breast cancer 2Health News:Smoking causes stroke to occur 2Health News:Poor footwear linked to foot impairment and disability in gout patients 2Health News:Older people are happier in Brazil and South Africa 2
    Keeler Professional Combi Retinoscope with new slimline handle and lithium or dry cell option....
    System, English (Continental cord), 230 VAC....
    300XL System, English (U.K. cord), 100-240 VAC....
    Micro-mini fiber optic light....
    Medicine Products: